Menu
Search
|

Menu

Close
X

Hualan Biological Engineering Inc 002007.SZ (Shenzhen Stock Exchange)

25.88 CNY
+0.26 (+1.01%)
As of Feb 23
chart
Previous Close 25.62
Open 25.77
Volume 3,623,319
3m Avg Volume 7,312,790
Today’s High 25.94
Today’s Low 25.57
52 Week High 37.73
52 Week Low 24.28
Shares Outstanding (mil) 930.09
Market Capitalization (mil) 24,070.67
Forward P/E 30.39
Dividend (Yield %) 0.40 ( 1.55 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.06 Mean rating from 18 analysts

KEY STATS

Revenue (mm, CNY)
FY17
1,666
FY16
1,935
FY15
1,472
EPS (CNY)
FY17
0.666
FY16
0.839
FY15
0.717
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
30.39
33.62
Price to Sales (TTM)
vs sector
10.97
8.35
Price to Book (MRQ)
vs sector
5.39
5.22
Price to Cash Flow (TTM)
vs sector
--
25.88
Total Debt to Equity (MRQ)
vs sector
0.00
15.84
LT Debt to Equity (MRQ)
vs sector
0.00
12.39
Return on Investment (TTM)
vs sector
18.21
13.63
Return on Equity (TTM)
vs sector
18.62
15.39

EXECUTIVE LEADERSHIP

Kang An
Chairman of the Board, General Manager, Since
Salary: --
Bonus: --
Junmin Xie
Chief Financial Officer, Secretary of the Board, Since 2013
Salary: --
Bonus: --
Bei Fan
Executive Deputy General Manager, Director, Since 2013
Salary: --
Bonus: --
Ruowen Pan
Deputy General Manager, Director, Since 2013
Salary: --
Bonus: --
Qiping Wang
Deputy General Manager, Director, Since 2013
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

No.A1, Hualan Avenue
XINXIANG   HEN   453003

Phone: +86373.3559989

HUALAN BIOLOGICAL ENGINEERING, INC. is a China-based company principally engaged in the research, development, production and sales of blood products. It also produces vaccine products and biological engineering products. The Company's main products include human albumins, human immunoglobulin for intravenous injection, human immunoglobulin, human coagulation factors, human rabies immunoglobulin, human tetanus immunoglobulin and influenza vaccines, among others. The Company mainly operates its businesses in domestic markets.

SPONSORED STORIES